Cytidine Triphosphate Synthetase Activity in Lymphoproliferative Disorders1

Total Page:16

File Type:pdf, Size:1020Kb

Cytidine Triphosphate Synthetase Activity in Lymphoproliferative Disorders1 [CANCER RESEARCH 43, 1432-1435, March 1983] 0008-5472/83/0043-0000302.00 Cytidine Triphosphate Synthetase Activity in Lymphoproliferative Disorders1 Peter H. Ellims,1 2 T. Eng Gan, and Gabriele Medley Department of Medicine, Monash University, Alfred Hospital, Prahran, 3181, Victoria ¡P.H. £., T. E. G.I, and Division of Anatomical Pathology, Prince Henry's Hospital, Melbourne. 3004. Victoria [G. M.], Australia ABSTRACT has been correlated directly with the growth rate of various rat hepatomas (23, 25), indicating that the enzyme is a marker of Cytidine triphosphate synthetase (CTP synthetase) activity the proliferative rate and biological aggressiveness of these was measured in extracts from normal and malignant lymphoid tumors. Preliminary data show that there is an increase in the cells. A range of enzyme activities was found in the majority of CTP synthetase activity of other rodent tumors and in human the lymphoproliferative disorders examined, with acute lym- renal cell carcinoma, but the tumor specificity of this phenom phocytic leukemia, nodular poorly differentiated lymphocytic enon is unclear (25). In addition, CTP synthetase activity is lymphoma, and diffuse histiocytic (large cell) lymphoma (DHL) thought to be capable of modulating the cytotoxic effect of types exhibiting the widest ranges. The highest levels occurred some pyrimidine antimetabolites. The intracellular CTP levels in acute lymphocytic leukemia, nodular poorly differentiated can influence the effect of 5-azacytidine by its inhibitory effect lymphocytic lymphoma transforming to DHL, and DHL. In on the rate of the uridine-cytidine kinase reaction and by chronic lymphocytic leukemia and diffuse well-differentiated competition with the active metabolite 5-azacytidine triphos lymphocytic lymphoma, a narrow range was encountered, with phate (12). Similarly, the intracellular dCTP pool opposes the individual values falling within that of the controls. The highest CTP synthetase levels in Hodgkin's disease were found in the action of 1-ß-D-arabinofuranosylcytosine triphosphate, the ac tive metabolite of ara-C3 (11), and 5-azadeoxycytidine triphos clinically aggressive lymphocyte-depleted Hodgkin's disease. phate, the active metabolite of 5-azadeoxycytidine (18). Re Statistically significant differences were found between the cently, a mutant type of CTP synthetase has been associated distributions of CTP synthetase activities in acute lymphocytic with expanded intracellular dCTP and CTP pools and, as a leukemia and the chronic leukemias (p < 0.01) and between favorable histological types of non-Hodgkin's lymphoma (dif consequence, resistance to ara-C and thymidine (19). Finally, inhibition of CTP synthetase by the metabolite deazauridine fuse well-differentiated, nodular poorly differentiated, and dif triphosphate is believed to be the primary mode of action of fuse poorly differentiated lymphocytic lymphoma) and the un the investigational antileukemic agent DAU (17). favorable DHL category (p < 0.05). It is suggested that CTP In view of these data, a study was undertaken of the profile synthetase activity is a biochemical marker of the clinical of CTP synthetase activity in lymphoproliferative disorders. aggressiveness of malignant lymphoma. There was not a close correlation (r2 = 0.52) between CTP synthetase and thymidine kinase activities, indicating that other biological factors in ad MATERIALS AND METHODS dition to cell proliferative rate influence the intracellular CTP Materials. [5,6-3H]UTP (43 Ci/mmol) and [6-3H]thymidine (5 Ci/ synthetase level. Furthermore, in view of the heterogeneity of mmol) were purchased from the Radiochemical Centre, Amersham, CTP synthetase activity in leukemia and lymphoma, it is likely England. Nucleotides and Dowex 50W-X8 (200 to 400 mesh) were that the preexisting enzyme level will be an important determi obtained from Sigma Chemical Co., St. Louis, Mo. Polygram CEL 300 nant of the efficacy of the investigational antileukemic agent 3- PEI/UV254 thin-layer chromatography plates were supplied by Brink- deazauridine, which is thought to act by inhibiting CTP synthe mann, Inc., New York, N. Y. PCS scintillation counting fluid was tase. obtained from Amersham, Amersham, England. All other chemicals used were of analytical grade and were obtained from commercial sources. INTRODUCTION Patients Studied. Peripheral blood lymphocytes were obtained from CTP synthetase (UTP:L-glutamine ligase, EC 6.3.4.2) cata a control group, which contained 10 normal volunteers and 9 patients with nonneoplastic disorders. Seven lymph nodes obtained at surgical lyzes the formation of CTP from the substrate DTP. The precise biopsy and showing normal histology or minimal reactive changes biochemical role of mammalian CTP synthetase activity is un formed a second control group. certain, but the enzyme is thought to play an important part in Patients with lymphoproliferative disorders were all previously un the determination of cellular CTP and dCTP pools (19, 25). treated. They included 11 patients with B-CLL,4 all of whom exhibited Recent data suggest that, in addition to this physiological role, an absolute peripheral blood lymphocytosis (range 15,800 to 69,0007 CTP synthetase is uniquely important in the pyrimidine metab olism of mammalian tumors (25). It has been established that 3 The abbreviations used are: ara-C, 1-/8-D-arabinofuranosylcytosine; DAU, 3- deazauridine; B-CLL, bone marrow-derived chronic lymphocytic leukemia; CLL, there is a specific increase in the CTP synthetase activity and chronic lymphocytic leukemia; T-CLL, thymus-derived chronic lymphocytic leu content of rat hepatomas over that found in normal liver (23; kemia; HCL, hairy cell leukemia; ALL, acute lymphocytic leukemia; Thy-ALL, T- cell acute lymphocytic leukemia; C-ALL, common-ALL antigen ALL; null-ALL, 25). Furthermore, the degree of increase in CTP synthetase null-cell ALL; NHL, non-Hodgkin's lymphoma; DWDLL, diffuse well-differentiated lymphocytic lymphoma; NPDLL, nodular poorly differentiated lymphocytic lym ' The investigation was supported in part by grants from the National Health phoma; DPDLL, diffuse poorly differentiated lymphocytic lymphoma; DHL, diffuse histiocytic (large cell) lymphoma; HD, Hodgkin's disease. and Medical Research Council of Australia. 2 Applied Health Fellow of the National Health and Medical Research Council 4 Lymphocyte immunological typing studies were kindly performed by mem of Australia. To whom requests for reprints should be addressed. bers of the Clinical Immunology Unit, Peter MacCallum Clinic, Melbourne, Aus Received April 6, 1982; accepted December 3, 1982. tralia. 1432 CANCER RESEARCH VOL. 43 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 1983 American Association for Cancer Research. CIP Synthetase of Lymphoproliferative Disorders /il) with the majority of cells exhibiting faint immunofluorescence for the validity of this procedure was confirmed by polyethyleneimine monoclonal IgM or IgM-lgD and mouse erythrocyte receptor positivity. cellulose thin-layer chromatography (26). Under the experimental con Two additional patients with CLL were identified as T-CLL by the ability ditions used, 82 to 87% of [3H]CTP was recovered as [3H]CMP. The of the majority of peripheral blood lymphocytes (range 30,960 to reaction was linear with respect to protein concentration and for up to 75,800//il) to spontaneously bind sheep erythrocytes. Anti-T mono 75 min. Enzyme activity was expressed as nmol of CTP formed per hr clonal antibody studies showed that the majority of peripheral blood per mg of protein. lymphocytes expressed the phenotype of helper T-lymphocytes (OKT4) Thymidine Kinase Assay. Thymidine kinase was assayed as previ in one patient with T-CLL, whereas, in the second patient, the peripheral ously described using [6-3H]thymidine as the radiolabeled substrato (8, blood lymphocytes exhibited the phenotypic features of suppressor T- 9). lymphocytes (OKT8). One patient had HCL with more than 80% of the Protein was determined by the method of Bradford (5) using bovine peripheral blood lymphocytes (32,350/jul) being abnormal and exhibit serum albumin as the standard. ing tartrate-resistant acid phosphatase activity. Seven patients had ALL. Lymphoblasts were the predominant peripheral blood mononu- RESULTS clear cell in all 7 patients. Peripheral blood lymphoblasts from 2 patients (range 8,430 to 22,100//¿I) were identified as Thy-ALL by CTP Synthetase Activity in Control Blood Lymphocytes their ability to form spontaneous rosettes with sheep erythrocytes. and Lymph Nodes. Peripheral blood lymphocytes from normal Peripheral lymphoblasts from 4 patients (range 4,380 to 12,100 fil) did not show T- or B-lymphocyte surface markers but did express the C- individuals and patients with nonneoplastic medical disorders ALL antigen and were classified as C-ALL. One patient was considered had a mean CTP synthetase activity of 0.91 ± 0.20 (S.D.) to have null-ALL on the basis that the peripheral blood lymphoblasts nmol/hr/mg of protein (range, 0.78 to 1.30). Tissue extracts '6,760/jul) did not express T- or B-cell markers or the C-ALL antigen. from normal lymph nodes and those exhibiting minimal reactive Lymph nodes were obtained at surgical biopsy, and the histological changes had a mean enzyme activity of 1.18 ±0.19 nmol/hr/ findings were independently reviewed by G. Medley. In 41 patients, mg of protein (range, 0.95 to 1.40). the histological findings were those of NHL, which were categorized CTP Synthetase Activity in ALL
Recommended publications
  • Copyright by Jeremy Daniel O'connell 2012
    Copyright by Jeremy Daniel O’Connell 2012 The Dissertation Committee for Jeremy Daniel O’Connell Certifies that this is the approved version of the following dissertation: Systemic Protein Aggregation in Stress and Aging Restructures Cytoplasmic Architecture Committee: Edward Marcotte, Supervisor Dean Appling Andrew Ellington Makkuni Jayaram Scott Stevens Systemic Protein Aggregation in Stress and Aging Restructures Cytoplasmic Architecture by Jeremy Daniel O’Connell, B.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin September 2012 Dedication Cytisus laburnum, simul vincet omnem To my dad and mom who encouraged and enabled my education with countless sacrifices, I promised this graduation would be the one we would attend, and I am truly sorry I was not swift enough to make that possible. Acknowledgements Foremost, I thank my advisor Edward Marcotte, for not just a second lease on a life in science but one in an amazing lab environment. His intellectual rigor, enduring patience, amazing work ethic, and enthusiasm for discovery were an inspiration. I thank my collaborators in this project: Gwen Stovall, Alice Zhao, Gabe Wu, and Mark Tsechansky for their comradery and support on this great adventure. I thank the talented undergraduates: Maguerite West-Driga, Ariel Royall, and Tyler McDonald who stuck with me. Each of you will soon be a better scientist than I ever will, and I hope you enjoyed and learned from our research together nearly as much as I did.
    [Show full text]
  • The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (Cad) by Phosphorylation and Protein-Protein Interactions
    THE REGULATION OF CARBAMOYL PHOSPHATE SYNTHETASE-ASPARTATE TRANSCARBAMOYLASE-DIHYDROOROTASE (CAD) BY PHOSPHORYLATION AND PROTEIN-PROTEIN INTERACTIONS Eric M. Wauson A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Pharmacology. Chapel Hill 2007 Approved by: Lee M. Graves, Ph.D. T. Kendall Harden, Ph.D. Gary L. Johnson, Ph.D. Aziz Sancar M.D., Ph.D. Beverly S. Mitchell, M.D. 2007 Eric M. Wauson ALL RIGHTS RESERVED ii ABSTRACT Eric M. Wauson: The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (CAD) by Phosphorylation and Protein-Protein Interactions (Under the direction of Lee M. Graves, Ph.D.) Pyrimidines have many important roles in cellular physiology, as they are used in the formation of DNA, RNA, phospholipids, and pyrimidine sugars. The first rate- limiting step in the de novo pyrimidine synthesis pathway is catalyzed by the carbamoyl phosphate synthetase II (CPSase II) part of the multienzymatic complex Carbamoyl phosphate synthetase, Aspartate transcarbamoylase, Dihydroorotase (CAD). CAD gene induction is highly correlated to cell proliferation. Additionally, CAD is allosterically inhibited or activated by uridine triphosphate (UTP) or phosphoribosyl pyrophosphate (PRPP), respectively. The phosphorylation of CAD by PKA and ERK has been reported to modulate the response of CAD to allosteric modulators. While there has been much speculation on the identity of CAD phosphorylation sites, no definitive identification of in vivo CAD phosphorylation sites has been performed. Therefore, we sought to determine the specific CAD residues phosphorylated by ERK and PKA in intact cells.
    [Show full text]
  • Classical and Rational Approaches to Antifungal Drug Design
    Classical and rational approaches to antifungal drug design Jessica Louise Chitty BSc (Hons) A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2017 School of Chemistry and Molecular Biosciences Institute of Molecular Biosciences Abstract The emergence of human immunodeficiency virus (HIV) in the 1980s has led to an increase in infections from previously rare pathogens. Many of these now cause widespread infection among individuals with compromised immune systems, not just limited to AIDS patients but also to those placed on immunosuppressive medication. The encapsulated yeast Cryptococcus neoformans causes widespread disease in the immunocompromised population, particularly in sub-Saharan Africa where it is a major cause of AIDS-related mortality due in part to limited resources and variable drug availability. Current treatment options are restricted to three out-dated antifungals amphotericin B, flucytosine and fluconazole; where possible they are used in combination as nephrotoxicity and resistance are contributing factors in the unacceptably high mortality rates. Alternative therapeutic agents are urgently required to improve survival rates and combat antifungal drug resistance. Two main routes of compound development can be taken: classical drug screening or rational drug design. Classical design requires groups of compounds to be screened against pathogens and those identified with high efficacy and low cytotoxicity are pursued. Rational drug design requires a detailed characterization of the proposed target; exploitable differences between the pathogen and human host are sought out as potential druggable targets. In this thesis both classical and rational methods have been investigated. A classical approach was taken to investigate a class of octapeptin compounds, produced as secondary metabolites by the soil dwelling bacterium, Bacillus circulans.
    [Show full text]
  • Uva-DARE (Digital Academic Repository)
    UvA-DARE (Digital Academic Repository) The pivotal role of CTP synthetase in the metabolism of (deoxy)nucleosides in neuroblastoma Bierau, J. Publication date 2003 Link to publication Citation for published version (APA): Bierau, J. (2003). The pivotal role of CTP synthetase in the metabolism of (deoxy)nucleosides in neuroblastoma. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:27 Sep 2021 1 1 Introduction n "Nucleotidess are water-soluble components which naturally occur, inn larger or smaller portions, in both animal and vegetable foods. Combinedd with other components, theyy are the elements to bring the flavor in food." fromm the Ajinomoto Europe website ChapterChapter 1 Introduction n 1.11 General introduction to neuroblastoma Incidence Incidence Neuroblastomaa is the most common extra cranial solid cancer of childhood.
    [Show full text]
  • 1611 REGULATION of PYRIMIDINE METABOLISM in PLANTS Chris
    [Frontiers in Bioscience 9, 1611-1625, May 1, 2004] REGULATION OF PYRIMIDINE METABOLISM IN PLANTS 1, 2 1, 3 1, 4 1, 5 1, 6 1, 7 Chris Kafer , Lan Zhou , Djoko Santoso , Adel Guirgis , Brock Weers , Sanggyu Park and Robert Thornburg 1 1 Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa 50011, 2 BASF Plant Science LLC, 2901 South Loop Drive, Ste 3800, Ames, Iowa 50014, 3 Lan Zhou, Pioneer Hi-Bred International, Inc. 7300 NW 62nd Avenue, PO Box 1004, Johnston, Iowa 50131-1004, 4 Indonesian Biotechnology Research Institute for Estate Crops, Jl, Taman Kencana No 1, Bogor 16151 Indonesia, 5 Institute of Genetic Engineering and Biotechnology, Menofiya University, PO Box 79/22857, Sadat City, Egypt, 6 Department of Biochemistry, University of Iowa, 4/511 Bowen Science Building, Iowa City, Iowa 52242-1109, 7 Division of Life and Environment, College of Natural Resources, Daegu University, Gyongsan City, Gyongbuk, Korea 712-714 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Pyrimidine metabolic pathways 3.1. De novo pyrimidine biosynthesis 3.1.1. CPSase 3.1.2. ATCase 3.1.3. DHOase 3.1.4. DHODH 3.1.5. UMPS 3.1.6. Intracellular Organization of the de novo Pathway 3.2. Pyrimidine Salvage and Recycling 3.2.1. Cytosine deaminase 3.2.2. Cytidine deaminase 3.2.3. UPRTase 3.3. Pyrimidine Modification 3.3.1. UMP/CMP kinase 3.3.2. NDP kinase 3.3.3. CTP synthase, NDP reductase, dUTPase 3.3.4. Thymidylate synthase/Dihydrofolate reductase 3.4. Pyrimidine Catabolism 4. Regulation of pyrimidine metabolism 4.1.
    [Show full text]
  • Developmental Disorder Associated with Increased Cellular Nucleotidase Activity (Purine-Pyrimidine Metabolism͞uridine͞brain Diseases)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 11601–11606, October 1997 Medical Sciences Developmental disorder associated with increased cellular nucleotidase activity (purine-pyrimidine metabolismyuridineybrain diseases) THEODORE PAGE*†,ALICE YU‡,JOHN FONTANESI‡, AND WILLIAM L. NYHAN‡ Departments of *Neurosciences and ‡Pediatrics, University of California at San Diego, La Jolla, CA 92093 Communicated by J. Edwin Seegmiller, University of California at San Diego, La Jolla, CA, August 7, 1997 (received for review June 26, 1997) ABSTRACT Four unrelated patients are described with a represent defects of purine metabolism, although no specific syndrome that included developmental delay, seizures, ataxia, enzyme abnormality has been identified in these cases (6). In recurrent infections, severe language deficit, and an unusual none of these disorders has it been possible to delineate the behavioral phenotype characterized by hyperactivity, short mechanism through which the enzyme deficiency produces the attention span, and poor social interaction. These manifesta- neurological or behavioral abnormalities. Therapeutic strate- tions appeared within the first few years of life. Each patient gies designed to treat the behavioral and neurological abnor- displayed abnormalities on EEG. No unusual metabolites were malities of these disorders by replacing the supposed deficient found in plasma or urine, and metabolic testing was normal metabolites have not been successful in any case. except for persistent hypouricosuria. Investigation of purine This report describes four unrelated patients in whom and pyrimidine metabolism in cultured fibroblasts derived developmental delay, seizures, ataxia, recurrent infections, from these patients showed normal incorporation of purine speech deficit, and an unusual behavioral phenotype were bases into nucleotides but decreased incorporation of uridine.
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]
  • University of Cincinnati
    UNIVERSITY OF CINCINNATI Date: 22-Jan-2010 I, Amruta Desai , hereby submit this original work as part of the requirements for the degree of: Master of Science in Computer Engineering It is entitled: Design support for biomolecular systems Student Signature: Amruta Desai This work and its defense approved by: Committee Chair: Carla Purdy, C, PhD Carla Purdy, C, PhD Wen-Ben Jone, PhD Wen-Ben Jone, PhD George Purdy, PhD George Purdy, PhD 2/2/2010 389 Design Support for Biomolecular Systems A thesis submitted to the Division of Graduate Research and Advanced Studies of The University of Cincinnati In partial fulfillment of the Requirements for the degree of Master of Science in the Department of Electrical and Computer Engineering of the College of Engineering By Amruta Desai BE in Electrical Engineering, Rajiv Gandhi Technical University, 2005 January, 2010 Thesis Advisor and Committee Chair: Dr. Carla Purdy Abstract Systems biology is an emerging field which connects system level understanding to molecular level understanding. Biomolecular systems provide a comprehensive view of a biological phenomenon, in the form of a network of inter-related reactions or processes. The work described in this thesis focuses on developing the support for virtual experiments in systems biology. This will help biologists to make choices about which wet lab experiments are likely to be the most informative, thereby saving both time and material resources. Our goal is to support synthetic biology by providing tools which can be employed by biologists, engineers, and computational scientists. Our approach makes use of well-developed techniques from the field of VLSI design.
    [Show full text]
  • Active Site Coupling in Plasmodium Falciparum GMP Synthetase Is Triggered by Domain Rotation
    ARTICLE Received 7 May 2015 | Accepted 19 Oct 2015 | Published 23 Nov 2015 DOI: 10.1038/ncomms9930 OPEN Active site coupling in Plasmodium falciparum GMP synthetase is triggered by domain rotation Lionel Ballut1,*, Se´bastien Violot1,*, Santosh Shivakumaraswamy2,*, Lakshmi Prasoona Thota2, Manu Sathya2, Jyothirmai Kunala2, Bauke W. Dijkstra3, Raphae¨l Terreux4, Richard Haser1, Hemalatha Balaram2 & Nushin Aghajari1 GMP synthetase (GMPS), a key enzyme in the purine biosynthetic pathway performs catalysis through a coordinated process across two catalytic pockets for which the mechanism remains unclear. Crystal structures of Plasmodium falciparum GMPS in conjunction with mutational and enzyme kinetic studies reported here provide evidence that an 85° rotation of the GATase domain is required for ammonia channelling and thus for the catalytic activity of this two-domain enzyme. We suggest that conformational changes in helix 371–375 holding catalytic residues and in loop 376–401 along the rotation trajectory trigger the different steps of catalysis, and establish the central role of Glu374 in allostery and inter- domain crosstalk. These studies reveal the mechanism of domain rotation and inter-domain communication, providing a molecular framework for the function of all single polypeptide GMPSs and form a solid basis for rational drug design targeting this therapeutically important enzyme. 1 BioCrystallography and Structural Biology of Therapeutic Targets Group, Molecular and Structural Bases of Infectious Systems, UMR5086 CNRS-University of Lyon 1, 7 passage du Vercors, 69367 Lyon Cedex 07, France. 2 Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064, India. 3 Laboratory of Biophysical Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
    [Show full text]
  • Staphylococcus Aureus Infection Reduces Nutrition Uptake and Nucleotide Biosynthesis in a Human Airway Epithelial Cell Line
    H OH metabolites OH Article Staphylococcus aureus Infection Reduces Nutrition Uptake and Nucleotide Biosynthesis in a Human Airway Epithelial Cell Line Philipp Gierok 1, Manuela Harms 2, Karen Methling 1, Falko Hochgräfe 2 and Michael Lalk 1,* 1 Institute of Biochemistry, University of Greifswald, 17487 Greifswald, Germany; [email protected] (P.G.); [email protected] (K.M.) 2 Competence Center Functional Genomics, Junior Research Group Pathoproteomics, University of Greifswald, 17487 Greifswald, Germany; [email protected] (M.H.); [email protected] (F.H.) * Correspondence: [email protected]; Tel.: +49-3834-86-4867 Academic Editors: Wolfgang Eisenreich and Adelbert Bacher Received: 6 October 2016; Accepted: 2 November 2016; Published: 9 November 2016 Abstract: The Gram positive opportunistic human pathogen Staphylococcus aureus induces a variety of diseases including pneumonia. S. aureus is the second most isolated pathogen in cystic fibrosis patients and accounts for a large proportion of nosocomial pneumonia. Inside the lung, the human airway epithelium is the first line in defence with regard to microbial recognition and clearance as well as regulation of the immune response. The metabolic host response is, however, yet unknown. To address the question of whether the infection alters the metabolome and metabolic activity of airway epithelial cells, we used a metabolomics approach. The nutrition uptake by the human airway epithelial cell line A549 was monitored over time by proton magnetic resonance spectroscopy (1H-NMR) and the intracellular metabolic fingerprints were investigated by gas chromatography and high performance liquid chromatography (GC-MS) and (HPLC-MS). To test the metabolic activity of the host cells, glutamine analogues and labelled precursors were applied after the infection.
    [Show full text]
  • 190323111.Pdf
    Characterization of polymers of nucleotide biosynthetic enzymes By Sajitha Anthony April, 2017 A dissertation presented to the faculty of Drexel University College of Medicine in partial fulfillment for the requirements for the degree of Doctor of Philosophy in Molecular and Cellular Biology and Genetics i ii ACKNOWLEDGEMENTS First and foremost, I would like to thank my mentor Dr. Jeffrey Peterson for all of his support and guidance throughout the five years that I have been in his lab. He has truly inspired me with his tremendous enthusiasm for science and his constant encouragement. He has changed, for the better, the way I approach and see science. I could not have asked for a better mentor. Secondly, I would like to thank my committee members for all of their great ideas and their never-ending support. I thank them for answering all of my questions so patiently and always listening to what I had to say. After every meeting I’ve had with them, I always felt encouraged and confident. I would also like to thank my collaborators over at the University of Washington—Justin Kollman, Anika Burrell, and Matthew Johnson. It has been such a pleasure working with them. The journey of discovery that we took together has been very exciting. This was my first collaboration, and they have made it such a memorable and positive experience. iii I would like to thank my lab members, in particular Alex for being an awesome cubemate, colleague, and friend. He has been the sounding board for so many of my project’s ideas over the years and has given such knowledgeable input.
    [Show full text]
  • Nucleo'de)Metabolism) (Chapter)23)) INTRODUCTION)TO)NUCLEIC)ACIDS)
    BIOCH 765: Biochemistry II Spring 2014 Nucleo'de)Metabolism) (Chapter)23)) Jianhan)Chen) Office)Hour:)MF)1:30B2:30PM,)Chalmers)034) Email:)[email protected]) Office:)785B2518) INTRODUCTION)TO)NUCLEIC)ACIDS) (c))Jianhan)Chen) 2) Eukaryo'c)cell) 3 Genome)is)believed)to)define)a)species) 4 Nucleic)Acids) • Polymer(of( nucleotides:(highly( flexible((compared( to(peptides)( • Nucleic(acids(are( universal(in(living( things,(as(they(are( found(in(all(cells( and(viruses.( • Nucleic(acids(were( first(discovered(by( Friedrich(Miescher( in(1871.( (c))Jianhan)Chen) 5 Building)Blocks)of)Nucleo'des) • Phosphate(group(+(pentose(carbohydrate(+( base((nitrogenGcontaining(heterocyclic(ring)( • Deoxyribonucleic(acid((DNA):(A/G/C/T( • Ribonuclei(acid((RNA):(A/G/C/U( Nucleotide nucleobase 6 Nucleo'des)have)many)roles) • Building(blocks(of(the(nucleic(acid(polymers(RNA(and( DNA.( • Energy(transfer(or(energy(coupling(to(drive(biosynthesis( and(other(processes((muscle(contraction,(transport,(etc).( • Oxidation(reduction(reactions.( • Intracellular(signaling.( ATP 7 Pentose)sugars) Base Phosphate sugar • The(pentose(sugar(in(the(nucloetide(is(either(ribose(or( deoxyribose.( ( – The(base(is(added(at(the(1(position(and(phosphates(are(added(at( the(5(position.( – Most(nucleotides,(including(those(incorporated(into(RNA,(contain( ribose.( – 2’GOH(reduced(to(–H(in(deoxynucleotides( – 3’GOH(participates(in(forming(phosphodiester(linkage( – Deoxynucleotides(are(exclusively(used(for(DNA(synthesis.( 8 Nucleo'de)forma'on) O ║ H N The base is added at the 1 6 N position and phosphates
    [Show full text]